CRMD

CorMedix Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website cormedix.com
Employees(FY) 40
ISIN US21900C3088

Performance

-2.28%

-22.58%

+22.25%

+97.92%

+127.93%

YTD

+146.97%

Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Advanced Technical Analysis

Technical Analysis of CRMD 2024-12-20

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 30, Oscillators Score at 36, and a Technical Score of 33, indicating overall weakness in price momentum and suggesting caution for potential investors. The consistently low scores across all categories reinforce a negative outlook for the stock in the near term.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of CRMD

Stock Rank

Recent News & Updates

2024-12-20 07:21
CorMedix price target raised to $12 from $11 at RBC Capital(TipRanks)
2024-12-19 08:30
CorMedix Inc. Added to Nasdaq Biotechnology Index(GlobeNewswire)
2024-12-18 19:30
CorMedix Inc. Added to Nasdaq Biotechnology Index(Globenewswire)
2024-11-26 08:30
CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products(GlobeNewswire)
2024-11-25 19:30
CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products(Globenewswire)
2024-11-04 08:30
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium(GlobeNewswire)
2024-11-04 05:37
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic(Simply Wall St.)
2024-11-03 19:30
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium(Globenewswire)
2024-11-01 08:21
While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate(Simply Wall St.)
2024-10-31 03:07
Cormedix Inc (CRMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses(GuruFocus.com)
2024-10-30 07:30
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update(GlobeNewswire)
2024-10-29 19:30
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update(Globenewswire)
2024-10-28 21:13
Cormedix Inc (CRMD) Q3 2024 Earnings Report Preview: What To Look For(Yahoo Finance)
2024-10-24 08:30
CorMedix Inc. Announces New Data at ASN Kidney Week 2024(GlobeNewswire)
2024-10-23 20:30
CorMedix Inc. Announces New Data at ASN Kidney Week 2024(Globenewswire)
2024-10-23 08:30
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024(GlobeNewswire)
2024-10-22 20:30
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024(Globenewswire)
2024-10-08 08:00
CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator(GlobeNewswire)
2024-10-07 20:00
CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator(Globenewswire)
2024-09-25 07:06
CorMedix Inc. (NASDAQ:CRMD): When Will It Breakeven?(Simply Wall St.)
2024-09-19 08:00
CorMedix Inc. Announces New Commercial Agreement(GlobeNewswire)
2024-09-18 20:00
CorMedix Inc. Announces New Commercial Agreement(Globenewswire)
2024-09-13 08:30
CorMedix Inc. to Present at the Cantor Global Healthcare Conference(GlobeNewswire)
2024-09-12 20:30
CorMedix Inc. to Present at the Cantor Global Healthcare Conference(Globenewswire)
2024-09-08 22:52
CorMedix Inc. Announces New Commercial Agreement(Globenewswire)
2024-08-15 08:05
We Think CorMedix (NASDAQ:CRMD) Can Afford To Drive Business Growth(Simply Wall St.)
2024-08-14 07:30
CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update(GlobeNewswire)
2024-08-13 19:30
CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update(Globenewswire)
2024-08-07 08:30
CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024(GlobeNewswire)
2024-08-06 20:30
CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.